Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Processes × Imatinib Mesylate × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12 Gastrointestinal Stromal Tumors 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia 5 Neoplasms 3 Neoplasm, Residual 2 Melanoma 2 Hematologic Neoplasms 2 Burkitt Lymphoma 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor Cancer 1 Rare Malignant Neoplasm 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Myeloproliferative Disorders 1 Mucositis 1 Lymphangioleiomyomatosis 1 Leukemia, Myeloid 1 Leukemia, Biphenotypic, Acute 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Digestive System Neoplasms 1 Desmoid Tumors 1 Dermatofibrosarcoma 1 Congenital Bone Marrow Failure Syndromes 1 Chordoma 1

Interventions

pembrolizumab 2 Pemetrexed 1 MRX-2843 1 Control Groups 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡